-+ 0.00%
-+ 0.00%
-+ 0.00%

MiNK Therapeutics Wins Grants to Advance Phase 1 Trial of Allo-iNKT Cell Therapy for GvHD Prevention

Reuters·01/08/2026 17:00:15

Please log in to view news